Sign in

CIK 0001870144 · <br>Emerging growth company

Cardio Diagnostics Holdings, Inc.

Sign in to watch
Ticker
CDIO
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
870925574
Phone
855-226-9991
Business address
311 W. SUPERIOR STREET, SUITE 444, CHICAGO, IL, 60645
Former names
Mana Capital Acquisition Corp.

Securities

  • CDIO Common stock Nasdaq
  • CDIOW Warrant Nasdaq
  1. S-1 Offering Registration Statement
  2. 8-K Event Shareholder vote results
  3. 10-Q Report Quarterly Report
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4/A Open-market buy Chief Technology Officer bought 68,965 shares at $0.29 ($20,000)
  9. 4/A Open-market buy Chief Executive Officer bought 68,965 shares at $0.29 ($20,000)
  10. 4/A Open-market buy Chief Executive Officer bought 68,965 shares at $0.29 ($20,000)
  11. DEFA14A Proxy Proxy Materials
  12. DEF 14A Proxy Proxy Statement
  13. ARS Other Annual Report to Security Holders
  14. PRE 14A Proxy Proxy Statement (Preliminary)
  15. 4/A Open-market buy Chief Technology Officer bought 68,965 shares at $0.29 ($20,000)
  16. 4 Open-market buy Chief Medical Officer bought 34,075 shares at an average $0.29 ($9,763)
  17. 4 Open-market buy Chief Technology Officer bought 68,965 shares at $0.29 ($20,000)
  18. 4 Open-market buy Chief Executive Officer bought 68,965 shares at $0.29 ($20,000)
  19. EFFECT Other Notice of Effectiveness
  20. POS AM Other Post-effective Amendment for Registration Statement

Page 5 of 15 · 296 filings